Guangdong VTR Bio-Tech Co Ltd (SHE:300381) — Stock Price
Guangdong VTR Bio-Tech Co Ltd (SHE:300381) is currently trading at CN¥6.15 CNY, up 2.84% today. Over the past 52 weeks, shares have ranged between CN¥5.40 and CN¥7.92. This page tracks Guangdong VTR Bio-Tech Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Guangdong VTR Bio-Tech Co Ltd market capitalisation.
Guangdong VTR Bio-Tech Co Ltd (300381) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Guangdong VTR Bio-Tech Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Guangdong VTR Bio-Tech Co Ltd Income Statement — Revenue, Profit & Earnings by Year
Guangdong VTR Bio-Tech Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥832.26 Million | CN¥826.20 Million | CN¥796.02 Million | CN¥1.17 Billion | CN¥1.89 Billion |
| Cost of Revenue | CN¥454.22 Million | CN¥460.33 Million | CN¥459.12 Million | CN¥816.91 Million | CN¥1.22 Billion |
| Gross Profit | CN¥378.04 Million | CN¥365.87 Million | CN¥336.90 Million | CN¥357.10 Million | CN¥675.22 Million |
| Research & Development | CN¥104.95 Million | CN¥109.32 Million | CN¥99.82 Million | CN¥99.87 Million | CN¥129.78 Million |
| SG&A | CN¥181.23 Million | CN¥91.55 Million | CN¥97.50 Million | CN¥159.71 Million | CN¥267.26 Million |
| Total Operating Expenses | CN¥832.13 Million | CN¥335.57 Million | CN¥320.98 Million | CN¥251.68 Million | CN¥758.36 Million |
| Operating Income | CN¥122.71K | CN¥30.30 Million | CN¥15.92 Million | CN¥105.42 Million | CN¥-83.14 Million |
| EBITDA | — | CN¥150.76 Million | CN¥116.42 Million | CN¥262.68 Million | CN¥115.91 Million |
| EBIT | — | CN¥38.89 Million | CN¥4.75 Million | CN¥124.83 Million | CN¥-51.95 Million |
| Interest Expense | CN¥730.56K | CN¥7.11 Million | CN¥3.47 Million | CN¥20.88 Million | CN¥36.77 Million |
| Income Before Tax | CN¥-16.43 Million | CN¥31.78 Million | CN¥1.28 Million | CN¥105.07 Million | CN¥-88.72 Million |
| Income Tax Expense | — | CN¥-169.71K | CN¥127.17K | CN¥67.55 Million | CN¥-3.29 Million |
| Net Income | CN¥-19.78 Million | CN¥31.09 Million | CN¥-10.75 Million | CN¥18.23 Million | CN¥-118.91 Million |
Guangdong VTR Bio-Tech Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Guangdong VTR Bio-Tech Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥2.92 Billion | CN¥2.95 Billion | CN¥3.09 Billion | CN¥3.17 Billion | CN¥4.48 Billion |
| Total Current Assets | CN¥1.11 Billion | CN¥1.28 Billion | CN¥1.69 Billion | CN¥2.04 Billion | CN¥1.95 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥198.72 Million | CN¥332.13 Million | CN¥563.70 Million | CN¥688.89 Million | — |
| Net Receivables | CN¥199.34 Million | CN¥235.89 Million | CN¥231.91 Million | CN¥253.89 Million | CN¥591.41 Million |
| Inventory | CN¥206.55 Million | CN¥194.71 Million | CN¥195.72 Million | CN¥205.37 Million | CN¥992.45 Million |
| Property, Plant & Equipment | — | — | — | CN¥708.22 Million | CN¥1.60 Billion |
| Goodwill | CN¥36.67 Million | CN¥36.67 Million | CN¥36.67 Million | CN¥36.67 Million | CN¥396.06 Million |
| Total Liabilities | CN¥331.81 Million | CN¥294.39 Million | CN¥359.79 Million | CN¥356.26 Million | CN¥1.43 Billion |
| Total Current Liabilities | CN¥279.41 Million | CN¥242.62 Million | CN¥308.86 Million | CN¥248.70 Million | CN¥1.17 Billion |
| Long-term Debt | — | — | — | CN¥51.32 Million | CN¥126.69 Million |
| Net Debt | — | CN¥-432.00 Million | CN¥-540.91 Million | CN¥-721.02 Million | CN¥570.83 Million |
| Total Stockholder Equity | CN¥2.55 Billion | CN¥2.61 Billion | CN¥2.61 Billion | CN¥2.71 Billion | CN¥2.79 Billion |
| Retained Earnings | CN¥434.47 Million | CN¥502.30 Million | CN¥501.06 Million | CN¥559.61 Million | CN¥627.16 Million |
Guangdong VTR Bio-Tech Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Guangdong VTR Bio-Tech Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥121.07 Million | CN¥69.19 Million | CN¥154.40 Million | CN¥249.77 Million | CN¥216.93 Million |
| Capital Expenditures | CN¥277.23 Million | CN¥377.40 Million | CN¥394.17 Million | CN¥197.78 Million | CN¥162.98 Million |
| Free Cash Flow | CN¥-156.16 Million | CN¥-308.20 Million | CN¥-239.77 Million | CN¥51.99 Million | CN¥53.95 Million |
| Investing Cash Flow | — | CN¥-80.95 Million | CN¥142.22 Million | CN¥-411.31 Million | CN¥-254.53 Million |
| Financing Cash Flow | — | CN¥43.05 Million | CN¥-214.25 Million | CN¥76.87 Million | CN¥36.62 Million |
| Dividends Paid | CN¥-49.10 Million | CN¥34.55 Million | CN¥51.06 Million | CN¥49.01 Million | CN¥34.27 Million |
| Stock-Based Compensation | — | — | — | CN¥5.58 Million | CN¥9.75 Million |
| Depreciation | CN¥128.94 Million | CN¥113.27 Million | CN¥112.09 Million | CN¥138.27 Million | CN¥167.86 Million |
| Change in Cash | CN¥-25.86 Million | CN¥28.67 Million | CN¥82.97 Million | CN¥-82.58 Million | CN¥-1.31 Million |
Guangdong VTR Bio-Tech Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Guangdong VTR Bio-Tech Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 31, 2026 | 0.03 | — | — |
| Dec 31, 2025 | -0.08 | — | — |
| Sep 30, 2025 | 0.01 | — | — |
| Jun 30, 2025 | 0.02 | — | — |
| Apr 22, 2025 | 0.01 | — | — |
| Dec 31, 2024 | -0.02 | — | — |
| Sep 30, 2024 | 0.00 | — | — |
| Aug 27, 2024 | 0.05 | — | — |